Lexicon Pharmaceuticals
LXRX
LXRX
86 hedge funds and large institutions have $221M invested in Lexicon Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 30 increasing their positions, 31 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
12% less capital invested
Capital invested by funds: $251M → $221M (-$30.3M)
15% less funds holding
Funds holding: 101 → 86 (-15)
71% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 17
Holders
86
Holding in Top 10
1
Calls
$475K
Puts
$129K
Top Buyers
| 1 | +$710K | |
| 2 | +$558K | |
| 3 | +$465K | |
| 4 |
Fisher Asset Management
Camas,
Washington
|
+$441K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$262K |
Top Sellers
| 1 | -$812K | |
| 2 | -$532K | |
| 3 | -$506K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$436K |
| 5 |
Walleye Capital
New York
|
-$420K |